Prof. Gilles Salles | ICML 2017 | L-MIND study, MOR208 + lenalidomide in R/R DLBCL

Anne Villeneuve

Gilles Salles

Jun 16, 2017

L-MIND study, MOR208 + lenalidomide in R/R DLBCL

More about...

Aggressive B-cell lymphomas Anne Villeneuve Diffuse large B-cell lymphoma Gilles Salles ICML 2017 L-MIND Lenalidomide Tafasitamab

New chemotherapy-free approaches for the treatment of lymphoid malignancies

At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances in chemotherapy-free options in the field of...

Jul 30, 2019

New chemotherapy-free approaches for the treatment of lymphoid malignancies

At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances...

Jul 30, 2019

ICML 2017 | Chemotherapy-free combinations for patients with B-cell NHL – Focus On Session

One of the “Focus On” Sessions at 14-ICML in Lugano, Switzerland, was based around chemotherapy-free combinations in patients with B-cell NHL, including those...

Jun 19, 2017

ICML 2017 | Chemotherapy-free combinations for patients with B-cell NHL – Focus On Session

One of the “Focus On” Sessions at 14-ICML in Lugano, Switzerland, was based around chemotherapy-free...

Jun 19, 2017

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. Gilles Salles | ICML 2017 | L-MIND study, MOR208 + lenalidomide in R/R DLBCL

Anne Villeneuve

Gilles Salles

Jun 16, 2017

More about...

Related articles

Jul 30, 2019

Jul 30, 2019

Jun 19, 2017

Jun 19, 2017

Newsletter